|
|
|
|
| LEADER |
04997nam a22003375i 4500 |
| 001 |
978-3-642-73316-1 |
| 005 |
20191024053345.0 |
| 007 |
cr nn 008mamaa |
| 008 |
121227s1988 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783642733161
|
| 024 |
7 |
|
|a 10.1007/978-3-642-73316-1
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Prostaglandins and Leukotrienes in Gastrointestinal Diseases
|c edited by W. Domschke, H.G. Dammann.
|
| 250 |
|
|
|a 1st ed. 1988.
|
| 260 |
# |
# |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 1988.
|
| 300 |
|
|
|a XVII, 332 p. 16 illus.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Biology and Pharmacology of Prostaglandins and Leukotrienes -- Biosynthesis and Metabolism of Prostaglandins and Thromboxanes. Quantitative Determination in Biological Material -- Discussion -- Involvement of the Eicosanoids, Thromboxane A2 and Leukotriene C4 in Gastric Mucosal Damage -- Discussion -- Microvascular Injury and the Role of Leukotrienes and Prostaglandins in Acute Mucosal Damage and Protection -- Discussion -- Inhibition of Prostaglandin Synthesis and Proliferation of the Gastric Mucosa -- Discussion -- Role of Prostaglandins in Intestinal Fluid Secretion -- Discussion -- Novel Leukotriene D4 Receptor Antagonists and 5-Lipoxygenase Inhibitors: Implications in Human Disease -- Discussion -- Protective Effects on the Gastrointestinal Mucosa. New Aspects of the Last two Years -- “Aggressive” and “Protective” Factors in the Pathogenesis of Peptic Ulcer Disease -- Discussion -- Heartburn and Mucosal Barrier Weakness -- Discussion -- The Functional Role of Prostanoids in the Gastroduodenal Mucosa -- Role of Leukotrienes in Gastric Mucosal Damage and Protection -- Discussion -- Effect of Prostaglandins on the Motility of the Digestive Tract -- Discussion -- Gastroduodenal Bicarbonate Secretion in Mucosal Protection -- Discussion -- Prostaglandins and Cellular Restitution — Physiological and Pathological Implications -- Discussion -- Prostanoid Inhibition of Acid Secretion — Cellular Mechanisms in Canine Fundic Mucosa -- Discussion -- The Protective Effects of Prostaglandins on the Gastric Microvasculature -- Non-Steroidal Anti-Inflammatory Drugs and Peptic Ulcer -- Discussion -- Mechanism of Injury to Gastric Mucosa by Non-Steroidal Anti-Inflammatory Drugs and the Protective Role of Prostaglandins -- Discussion -- Can Nonantisecretory Doses of Prostaglandins Prevent Mucosal Damage in Non-Steroidal Anti-Inflammatory Drugs? -- Clinical Aspects of the Protective Effects of Prostaglandins on Non-Steroidal Anti-Inflammatory Drug-Associated Mucosal Injury -- Discussion -- Prostaglandins and Leukotrienes in Gastrointestinal Diseases — Present Clinical Role -- Gastrointestinal Microbleeding and Ulcerogenic Drugs: Prevention by Co-Administration of Prostaglandins -- Discussion -- Exogenous Prostaglandins and Their Analogues in Gastric Ulcer Therapy -- Exogenous Prostaglandins and Their Analogues in Duodenal Ulcer Therapy -- Discussion -- Clinical Safety of Antiulcer Prostaglandins: An Overview -- Discussion -- Ulcer Healing Drugs and Endogenous Prostaglandins: Carbenoxolone, Antacids, Sucralfate, Bismuth, and H2-Receptor Antagonists -- Discussion -- Smoking and Ulcer Healing — Role for Prostaglandins? -- Discussion -- Ulcer Healing by Prostaglandins — Due to Decreased Acidity or Enhanced Mucosal Defense? -- Discussion -- Diarrheagenic Syndromes Sensitive to Prostaglandin Synthetase Inhibitors -- Discussion -- Colitis and Non-Steroidal Anti-Inflammatory Drugs -- Discussion -- Therapeutic Role for Prostaglandins in Ulcerative Colitis? -- Discussion -- Inflammatory Bowel Disease: Treatment Modalities and Mucosal Prostaglandin/Leukotriene Formation -- Discussion -- Prostaglandins: Their Potential Therapeutic Value in the Upper Gastrointestinal Tract -- The Natural History of Ulcer Disease and its Impact upon Therapeutic Options and Assessment of Drug Safety -- Benefits and Risks of Long-Term Medical Therapy with Histamine H2-Receptor Antagonists in Ulcer Disease — A Physician’s View -- Benefits and Risks of Long-Term Medical Therapy with Histamine H2-Receptor Antagonists in Ulcer Disease: A Surgeon’s View -- The Surgical Approach to Ulcer Disease and its Complications — Has there been a Change in the Last Decade? -- The Efficacy of Prostaglandins in the Prevention of Stress Lesions in the Critically I11 Patient -- Discussion Following this Section.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Hepatology.
|
| 650 |
|
0 |
|a Gastroenterology .
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Hepatology.
|
| 650 |
2 |
4 |
|a Gastroenterology.
|
| 700 |
1 |
|
|a Domschke, W.
|e editor.
|
| 700 |
1 |
|
|a Dammann, H.G.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-73316-1
|